Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 165 | 428 | 0 | 0 | 0 |
| Gross Profit | 165 | 428 | N/A | N/A | N/A |
| Operating Expenses | 13,065 | 11,754 | 21,218 | 19,187 | 18,382 |
| Operating Income | -12,900 | -11,326 | -21,218 | -19,187 | -18,382 |
| Interest Expense | 767 | 0 | 0 | 0 | 0 |
| Other Income | 660 | -334 | 236 | 216 | 174 |
| Pre-tax Income | -13,007 | -11,659 | -20,982 | -18,971 | -18,208 |
| Income Tax | 0 | 1 | -1 | -1 | 0 |
| Net Income Continuous | -13,007 | -11,660 | -20,982 | -18,970 | -18,208 |
| Net Income | $-13,007 | $-11,660 | $-20,982 | $-18,970 | $-18,208 |
| EPS Basic Total Ops | -8.50 | -9.35 | -17.86 | -17.69 | -18.88 |
| EPS Basic Continuous Ops | -8.55 | -9.29 | -17.80 | -17.67 | -18.80 |
| EPS Diluted Total Ops | -8.50 | -9.35 | -17.86 | -17.69 | -18.88 |
| EPS Diluted Continuous Ops | -8.55 | -9.29 | -17.80 | -17.67 | -18.80 |
| EPS Diluted Before Non-Recurring Items | -8.50 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-13,049 | $-11,506 | $-21,290 | $-18,930 | $-18,174 |